These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15843529)

  • 1. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis.
    Feferman T; Maiti PK; Berrih-Aknin S; Bismuth J; Bidault J; Fuchs S; Souroujon MC
    J Immunol; 2005 May; 174(9):5324-31. PubMed ID: 15843529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA microarray in search of new drug targets for myasthenia gravis.
    Feferman T; Aricha R; Menon R; Souroujon MC; Berrih-Aknin S; Fuchs S
    Ann N Y Acad Sci; 2007 Jun; 1107():111-7. PubMed ID: 17804538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
    Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
    J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.
    Feferman T; Aricha R; Mizrachi K; Geron E; Alon R; Souroujon MC; Fuchs S
    J Neuroimmunol; 2009 Apr; 209(1-2):87-95. PubMed ID: 19232748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG; Zhang GX; Xiao BG; Link H
    Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of IFN-gamma-inducible chemokines in inclusion body myositis.
    Raju R; Vasconcelos O; Granger R; Dalakas MC
    J Neuroimmunol; 2003 Aug; 141(1-2):125-31. PubMed ID: 12965263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.
    Albanesi C; Scarponi C; Sebastiani S; Cavani A; Federici M; De Pità O; Puddu P; Girolomoni G
    J Immunol; 2000 Aug; 165(3):1395-402. PubMed ID: 10903743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.
    Jinquan T; Jing C; Jacobi HH; Reimert CM; Millner A; Quan S; Hansen JB; Dissing S; Malling HJ; Skov PS; Poulsen LK
    J Immunol; 2000 Aug; 165(3):1548-56. PubMed ID: 10903763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats.
    Baggi F; Annoni A; Ubiali F; Milani M; Longhi R; Scaioli W; Cornelio F; Mantegazza R; Antozzi C
    J Immunol; 2004 Feb; 172(4):2697-703. PubMed ID: 14764745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity: a possible role for interferon-gamma-producing CD8(+) T cells in IP-10 expression.
    Tokuriki A; Seo N; Ito T; Kumakiri M; Takigawa M; Tokura Y
    J Dermatol Sci; 2002 Apr; 28(3):234-41. PubMed ID: 11912011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
    Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.
    Gasperini S; Marchi M; Calzetti F; Laudanna C; Vicentini L; Olsen H; Murphy M; Liao F; Farber J; Cassatella MA
    J Immunol; 1999 Apr; 162(8):4928-37. PubMed ID: 10202039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.
    García-López MA; Sancho D; Sánchez-Madrid F; Marazuela M
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5008-16. PubMed ID: 11600578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.
    Wang J; Zheng S; Xin N; Dou C; Fu L; Zhang X; Chen J; Zhang Y; Geng D; Xiao C; Cui G; Shen X; Lu Y; Wang J; Dong R; Qiao Y; Zhang Y
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1287-302. PubMed ID: 24043548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H
    Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma.
    Li HL; Shi FD; Bai XF; Huang YM; van der Meide PH; Xiao BG; Link H
    Clin Immunol Immunopathol; 1998 Apr; 87(1):15-22. PubMed ID: 9576006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.
    Christen U; McGavern DB; Luster AD; von Herrath MG; Oldstone MB
    J Immunol; 2003 Dec; 171(12):6838-45. PubMed ID: 14662890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
    Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
    Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.